Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson’s disease
Toxic aggregates of α-synuclein (αsyn) are considered key drivers of Parkinson’s disease (PD) pathology. In early PD, αsyn induces synaptic dysfunction also modulating the glutamatergic neurotransmission. However, a more detailed understanding of the molecular mechanisms underlying αsyn-triggered sy...
| Published in: | Pharmacological Research |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-09-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661822003206 |
